This continuing education activity is provided through collaboration between the Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare CE, and AffinityCE.
Educational Support for this upcoming live webinar and the enduring activity was provided by Takeda, Sanofi, Amicus Therapeutics, and Chiesi USA.